Scientists report that apratoxin S4, an anticancer drug candidate that targets a human protein, can intervene with the replication of many viruses, together with SARS-CoV-2 and influenza A, providing a attainable pan-viral remedy.
- Hubble sees crimson supergiant star Betelgeuse slowly recovering after blowing its prime
- Gross sales of Chinese language smartphones surge in Russia – media
- Russian star swaps Italian golf equipment
- US backs Israeli strikes on ‘dangerous guys’ in Gaza, envoy says
- Creating an 'adult-like' mature human cardiac tissue
5 recent posts for today:
- Moderna says its Covid vaccine is ‘properly tolerated’ in 6- to 11-year-olds after fears of coronary heart irritation in younger adults
- When paper cash goes to zero worth: Venezuelan hyperinflation defined (PHOTO)
- Promising cell applied sciences discover methane leaks rapidly
- Chelsea make Ronaldo resolution
- Joe Biden is working to reshape the federal judiciary by including Muslims to it